Recent advances in the management of nosocomial infections

JK Science

Volumn 9, Issue 1, 2007, Pages 3-8

  Jain, Atul ^a   Singh, Kanwardeep ^a  

^a SRI GURU RAM DAS INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZLOCILLIN; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; SULTAMICILLIN; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC THERAPY; BURKHOLDERIA CEPACIA; COMBINATION CHEMOTHERAPY; ENTEROBACTERIACEAE; ESCHERICHIA; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROFLORA; MONOTHERAPY; PROTEUS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA; TERTIARY HEALTH CARE;

EID: 34250755994     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Jarvis WE, Wartone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29 (A Suppl.): 19-24.
2. Wolff M, Burn-Buisson C, Lode H et al. The changing epidemiology of severe infections in the ICU. Clin Microb Infect 1997; 3 (I Suppl.): 36-47.
3. Aquino VM, Pappo A, Buchanan GR et al. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis 1995; 14: 140-43.
4. Vincent JL, Bihari DJ, Sutter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274: 639-45.
5. National Nosocomial Infections Surveillance (NNIS) System, Centers of Disease Cont rol and Prevention. National Nosocomial Infections (NNIS) report, data summary from October 1986 - April 1996. Am J Infect Control 1996; 24: 380-88.
6. Weinstein RA, Hayden MK. Multiply drug resistant pathogens: epidemiology and control. In: Bennett JV, Brachman PS, editors. Hospital infections. 4th ed. Philadelphia: Lippincott-Raven, 1998; 215-36.
7. Fraise AP. Epidemiology of resistance in intensive therapy units (ITUs). J Med Microbol 1997; 46: 447-49.
8. Bergogne-Bérézin E, Joly-Guillou ML. Hospital infection with Acinetobacter spp.: an increasing problem. J Hosp Infect 1991; 18 (A Suppl.): 250-55.
9. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care study. Eur J Clin Microbiol Infect Dis 1996; 15: 281-85.
10. Gould IM. Risk factors for acquisition of multiply-drug-resistant Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13 (I Suppl.): 30-38.
11. Clavo-Sanchez AJ, Giron-Gonzalez JA, Lopez-Prieto D, et al. Multivariate analysis of risk factors for infection due to penicillin resistant and multidrug resistant streptococcus pneuomiae: a multicenter study. Clin Infect Dis 1997; 24: 1052-59.
12. Péchère: JC. Microbiology of nosocomial infections. Bull Acad Natl Med 1993; 177: 705-17.
13. Penzak SR, Abate BJ. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug resistant nosocomial pathogen. Pharmacotherapy 1997; 17: 293-301.
14. Lecso-Bornet M, Bergogne Bérézin E. Susceptibility of Stenotrophomonas maltophilia to three β-lactams and five β-lactam-β-lactamase inhibitor combinations. J Antimicrob Chemother 1997; 40: 717-20.
15. Martone WJ, Jarvis WR, Edwards JR et al. Incidence and nature of endemic and epidemic and epidemic nosocomial infections. In: Bennett JV, Brachinan PS. editors. Hospital infections 4th ed. Philadelphia: Lippincott-Raven, 1998; 461-76.
16. Chastre J, Fagon JY, Trouillet JL. Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units. Clin Infect Dis 1995; 21 (3 Suppl.): S226-37.
17. Glauser M, Boogaerts M, Cordonnier C et al. Empiric therapy of bacterial infections in severe neutropenia. Clin Microb Infect 1997; 3 (A Suppl.): S77-86.
18. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25: 551-73.
19. Kessler RE, Fung-Tong J. Susceptibility of bacterial isolates to β-lactam antibiotics from US clinical trials over a 5-year period. Am J Med 1996; 100 (6A): 13S-9S.
20. Guyenbichler JP, Berchtold D, Allerberger F, et al. In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis 1992; 11: 408-15.
21. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, editor. Prevention and control of nosocomial infections. 3rd ed. Baltimore: William and Wilkins, 1997; 711-69.
22. Gaynes RP, Edwards JR, Jarvis WR et al. Nosocomial infections among neonates in high risk nurseries in the United States. Pediatrics 1996; 98: 357-61.
23. Selective Decontamination of the Digestive Tract Trialists Collaborative Group. Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. BMJ 1993; 307: 525-32.
24. Ostendorf U, Ewig S, Torres A. Nosocomial pneumonia. Curr Opin Infect Dis2006; 19(4): 327-38.
25. Cisneros-Herreros JM. Garnacho-Montero J, Pachon-Ibanez ME. Nosocomial pneumonia due to Acinetobacter. Enferm Infecc Microbiol Clin 2005; 23(3): 46-51.
26. Flanders SA, Collard HR. Saint S. Nosocomial pneumonia: state of the science. Am J Infect Control 2006; 34(2): 84-93.